• Seqster, Pryzm, Apple Tracking Symptoms, Spread, And Coronavirus Data

    Bio-IT World   Last week, several groups released COVID-19 screening tools or symptom checkers to help track the spread of the virus, help people make decisions about when to receive care, and track trends. Apple and Seqster both launched symptom trackers in the United States. Covidaware.me launched internationally to track symptoms and share data, and the TwinsUK study launched a COVID-19 symptom tracker and research study using a cohort of twins.

    Apr 2, 2020
  • Oxford Nanopore, Lifebit Biotech, Sinequa, And More: News From March 2020

    Bio-IT World March featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Oxford Nanopore, Lifebit Biotech, Sinequa, and more.

    Mar 30, 2020
  • New Virtual Reality Tool Simplifies Structure-Based Drug Design

    Bio-IT World | A virtual reality (VR) platform developed by researchers at the University of Bristol is allowing chemists, computational scientists and structural biologists to collaboratively design molecules like engineers create airplane components.

    Mar 27, 2020
  • Building A File System To Keep Up With Genomics England’s Five Million Genomes Project

    Bio-IT World When David Ardley took over the platforms function at Genomics England, he inherited “quite a challenging storage environment,” he told Bio-IT World. Genomics England expected to host over 140 petabytes of genomic data by 2023, and the current storage couldn't keep up. The group chose WekaIO to build the new storage environment. 

    Mar 24, 2020
  • Adaptive Biotechnologies, Microsoft Launch Immune Response Trial For COVID-19

    Bio-IT World Brief | Adaptive Biotechnologies and Microsoft today announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19 in a clinical trial to launch in April.

    Mar 20, 2020
  • BioTeam, NVIDIA, Globus, And More Offer Free Tools To Support Coronavirus Research

    Bio-IT World | Groups across the Bio-IT World community are offering their services and tools for free to teams working on coronavirus diagnostics and treatments. Offerings from BioTeam, Globus, NVIDIA, the Broad Institute, Rescale, Google Cloud, and Microsoft Azure all aim to speed work done on diagnostics and treatment.

    Mar 20, 2020
  • Matthew Trunnell On Data, Silos, COVID-19, And Advice To Himself 15 Years Ago

    Bio-IT World  TRENDS FROM THE TRENCHES—Stan Gloss and Matthew Trunnell discuss how their views of data have changed over the past two decades, what technologies provided tipping points, where the next leaps will happen, and what we may have done differently with the benefit of hindsight. And, of course, a little bit about coronavirus. 

    Mar 19, 2020
  • Summit Supercomputer Models Coronavirus 'Spike'

    Bio-IT World | As scientists across the globe bring their expertise to bear on the coronavirus pandemic, researchers in Tennessee are bringing big compute. Researchers are using Summit, the world’s fastest supercomputer housed at Oak Ridge National Laboratory (ORNL), to identify compounds that may effectively combat the virus. Summit is powered by 9,216 IBM Power9 CPUs and over 27,000 NVIDIA V100 Tensor Core GPUs.

    Mar 12, 2020
  • How Digital Technology Will Transform Every Part of Life Sciences in 2020

    Bio-IT World Contributed Commentary | Achieving a single view of the patient has been a key challenge for the life sciences industry, given the inherently siloed nature of organizations in the sector. However, as patient centricity increasingly becomes the crux of all life science organizations, the pace of digitization within the industry has picked up significantly.

    Mar 9, 2020
  • Navigating The Road To The Future In Life Sciences

    Bio-IT World Contributed Commentary | The pharma industry is at crossroad, where pricing pressures, focus on outcomes, complex drug portfolios and a challenging regulatory environment cast a shadow over it. However, these challenges also bring with them the opportunity to transform.

    Mar 5, 2020
  • Together, Doctors And AI Can Process “Helluvabytes” Of Data

    Bio-IT World | Data is the most valuable resource on the market today, and there’s a lot of it. When it comes to processing health data, the solution may be neural networks. Not AI to replace doctors, says Eric Topol, but AI to empower doctors.

    Mar 4, 2020
  • Liu Named 2020 Benjamin Franklin Award Laureate

    Bio-IT World | The Dana-Farber Cancer Institute and Harvard School of Public Health’s Xiaole Shirley Liu has been named the 2020 Benjamin Franklin Award Laureate, Bioinformatics.org announced today.

    Mar 3, 2020
  • Hints On Data Storage And Transport From High Energy Physics

    Bio-IT World | It may be surprising that with a PhD in biochemistry, Brigitte Raumann spends a lot of time these days considering data storage and transport in high energy physics and astronomy. But that also puts her in the perfect position to recognize some of the lessons from those disciplines that the life sciences can pick up.

    Mar 2, 2020
  • MGI Announces $100 Genome; Illumina Files Patent Suit

    Bio-IT World MGI got some attention with its presentation this week of the $100 genome. Among the feedback, a patent infringement suit from Illumina relating to the “CoolMPS” sequencing products.

    Feb 27, 2020
  • Illumina, NSA Labs, Certara, And More: News From February 2020

    Bio-IT World February featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Illumina, NSA Labs, Certara, and more.

    Feb 27, 2020
  • The Pistoia Alliance’s Releases Latest Unified Data Model

    Bio-IT World  The Pistoia Alliance yesterday released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS). V6 delivers a stable foundation for the collection and exchange of reaction data and empowers the community to move forward with its adoption. The release is built upon standard (Allotrope-compatible) vocabularies for units of measure and analytical methods, allowing the systems to be interoperable. As increased adoption of AI and ML in R&D continues, such industry-wide data standards are essential in the move toward the digitally driven Lab of the Future (LoTF).

    Feb 26, 2020
  • A Deep Look At The Future Of Medicine

    Bio-IT World  Cardiologist Eric Topol, author of the Creative Destruction of Medicine and The Patient Will See You Now has often written about medicine and technology. But Deep Medicine isn’t just about technology.

    Feb 26, 2020
  • New Players Take the Field: How Private Employer Healthcare Could Mean More Focus on People

    Bio-IT World Contributed Commentary | Depending on which side of the gurney you find yourself, the U.S. healthcare system can be simultaneously viewed as either a modern-day gold rush or an impossible financial burden. In large part, this is because humans have been displaced by business objectives as the focal point of healthcare. If you’re seeking some sign of restored equilibrium between massive healthcare corporations (59 of the S&P 500 companies are healthcare-related) and the individuals they are meant to serve, there’s an inkling of real change, growing out of an unlikely corner… other massive corporations. 

    Feb 25, 2020
  • MGI Announces April Availability Of Sequencers, Reagents In US

    Bio-IT World MGI, part of global genomics leader BGI Group, announced the commercial availability of its sequencing instruments and reagent kits in the United States based on MGI’s own innovative CoolMPS sequencing chemistry, starting in April of this year.

    Feb 21, 2020
  • The Value Of Imaging Data As The Missing Essential Component Of Real World Data

    Bio-IT World Contributed Commentary | Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).

    Feb 20, 2020